The Korea Research Institute of Standards and Science (KRISS) announced that they have developed an advanced disease ...

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025.

Researchers from Nanjing University and the Army Engineering University of PLA have published a review in ExRNA, shedding ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic alliance with VIDI Group, the largest private radiology and ...

Health experts are calling on leaders on the African continent to advocate for inequalities in access and production of ...

Bright Uro announced the second closing of its oversubscribed Series A funding round, securing a total of $32 million.

Robert LeBoyer, an analyst from Noble Financial, has initiated a new Buy rating on Zomedica Pharmaceuticals (ZOM). Robert LeBoyer’s ...

By Tarun Sai Lomte Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion ...